Atrial flutter medical therapy: Difference between revisions
| Line 16: | Line 16: | ||
====Electric Cardioversion==== | ====Electric Cardioversion==== | ||
Synchronous direct current (DC) cardioversion is used as the initial treatment strategy in the management of hemodynamically unstable atrial flutter patients in ED. External electric cardioversion is effective in more than 90% of the cases and the initial shock strength used is 50 joules biphasic direct current. Sometimes the first shock may convert an atrial flutter to atrial fibrillation, in such cases a second shock preferable of a higher strength is usually given to restore sinus rhythm. | Synchronous direct current (DC) cardioversion is used as the initial treatment strategy in the management of hemodynamically unstable atrial flutter patients in ED. External electric cardioversion is effective in more than 90% of the cases and the initial shock strength used is 50 joules biphasic direct current. Sometimes the first shock may convert an atrial flutter to atrial fibrillation, in such cases a second shock preferable of a higher strength is usually given to restore sinus rhythm. Electric cardioversion increases the risk of [[stroke]] and hence pre-treatment with a blood thinner is advised if time permits. | ||
====AV Nodal Agents==== | ====AV Nodal Agents==== | ||
Revision as of 04:07, 21 January 2013
|
Atrial flutter Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Atrial flutter medical therapy On the Web |
|
American Roentgen Ray Society Images of Atrial flutter medical therapy |
|
Risk calculators and risk factors for Atrial flutter medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
The management of atrial flutter is similar to that of atrial fibrillation with primary goals being control of ventricular rate, restoration of sinus rhythm, prevention of recurrent episodes and thromboembolic episodes. In the setting of unstable hemodynamics immediate electrical cardioversion is recommended. because of the high success rate and low complication rate radiofrequency ablation is considered superior to medical therapy in atrial flutter.
Medical Therapy
Management of Atrial Flutter in Emergency Department
Management of atrial flutter in emergency room depends on the hemodynamic state of the patient. Airway, breathing and circulation should be assessed first. Hemodynamically unstable patients are treated by electrical cardioversion initially. Ottawa Aggressive Protocol is a unique approach to cardioversion for ED patients with recent-onset episodes of atrial fibrillation and flutter. This approach is effective, safe and rapid and has the potential to reduce hospital admissions and expedite ED care[1]. Treatment options for atrial flutter in ED include:
- Electric cardioversion
- AV blocking agents and antiarrhythmic agents
- Rapid atrial pacing
Electric Cardioversion
Synchronous direct current (DC) cardioversion is used as the initial treatment strategy in the management of hemodynamically unstable atrial flutter patients in ED. External electric cardioversion is effective in more than 90% of the cases and the initial shock strength used is 50 joules biphasic direct current. Sometimes the first shock may convert an atrial flutter to atrial fibrillation, in such cases a second shock preferable of a higher strength is usually given to restore sinus rhythm. Electric cardioversion increases the risk of stroke and hence pre-treatment with a blood thinner is advised if time permits.
AV Nodal Agents
Ventricular rate control is the prime goal in the management of atrial flutter. Drugs like calcium channel blockers (verapamil or diltiazem) or beta-blockers can be used for this. These drugs act as AV node blocking agents and control ventricular rate, thereby preventing tachycardia induced cardiomyopathy. Administration of adenosine reveals flutter waves by blocking the AV node. History of Wolff-Parkinson-White syndrome or pre-excitation syndrome has to be ruled out before administrating, as these agents while acting on AV node can accelerate conduction in the accessory pathways and can precipitate ventricular fibrillation. Digoxin can also be used as an AV blocking agent in combination with calcium channel blockers and beta-blockers in the event of failure of electric cardioversion, atrial pacing and pharmacologic therapy.
Antiarrhythmic Agents
Class III agents like ibutilide, dofetilide, sotalol or amiodarone are typically used for pharmacologic cardioversion in the treatment of atrial flutter. Intravenous ibutilide is very effective in controlling acute atrial flutter episode and is found to be effective in at least 63% patients. Patients who are administered i.v ibutilide should be monitored using an EKG for at least 4 hrs after the infusion as ibutilide is known to cause QT prolongation and torsades de pointes.
Class IC agents like propafenone or flecainide have also shown to be effective in the conversion of acute onset atrial flutter to normal sinus rhythm.
References